David Daly

Directeur Général chez Exai Bio, Inc.

Profil

David J.
Daly's current job is as the Chief Executive Officer at Exai Bio, Inc. Formerly, Mr. Daly served as the Co-Chief Executive Officer & Director at Thrive Earlier Detection Corp.
from 2019 to 2021.
He also worked as the Director-US Sales-Animal Health Division at Abbott Laboratories.
Additionally, he held the position of Independent Director at NeoGenomics, Inc. from 2021 to 2023.
Mr. Daly was the Chief Commercial Officer & Senior Vice President at Clarient, Inc. from 2005 to 2012.
He also served as the SVP & General Manager-Commercial Operations at Illumina, Inc. from 2017 to 2019.
Furthermore, he worked as the Area Marketing Manager at Roche Diagnostics Corp.
and as the Vice President-Commercial Operations at Thermo Fisher Scientific, Inc. in 2014.
From 2014 to 2017, Mr. Daly held the position of Chief Commercial Officer & GM-Clinical Oncology at Foundation Medicine, Inc. He was also the President & Chief Operating Officer at Singular Genomics Systems, Inc. from 2021 to 2022.
Mr. Daly completed his undergraduate degree at the University of California, Irvine, and his graduate degree at the University of California, Santa Barbara.

Postes actifs de David Daly

Sociétés	Poste	Début
Exai Bio, Inc.	Directeur Général	24/07/2024

Anciens postes connus de David Daly

Sociétés	Poste	Fin
NEOGENOMICS, INC.	Directeur/Membre du Conseil	19/01/2023
SINGULAR GENOMICS SYSTEMS, INC.	President	03/06/2022
Thrive Earlier Detection Corp.	Directeur Général	01/01/2021
ILLUMINA, INC.	Corporate Officer/Principal	01/08/2019
FOUNDATION MEDICINE INC	Corporate Officer/Principal	11/08/2017